other material
confidence high
sentiment neutral
materiality 0.40
Eledon Pharmaceuticals completes $2.1M unregistered stock sale of 909,088 shares
Eledon Pharmaceuticals, Inc.
- Sold 909,088 shares of common stock in second closing under Securities Purchase Agreement dated April 28, 2023.
- Gross proceeds of approximately $2.1 million from institutional and accredited investors.
- Exempt from registration under Section 4(a)(2) and Rule 506(b).